3-50370310-C-T
Variant names:
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4BP6_Moderate
The NM_006030.4(CACNA2D2):c.2045+10G>A variant causes a intron change. The variant allele was found at a frequency of 0.0000444 in 1,575,614 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000040 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000045 ( 1 hom. )
Consequence
CACNA2D2
NM_006030.4 intron
NM_006030.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.32
Genes affected
CACNA2D2 (HGNC:1400): (calcium voltage-gated channel auxiliary subunit alpha2delta 2) Calcium channels mediate the entry of calcium ions into the cell upon membrane polarization. This gene encodes the alpha-2/delta subunit of the voltage-dependent calcium channel complex. The complex consists of the main channel-forming subunit alpha-1, and auxiliary subunits alpha-2/delta, beta, and gamma. The auxiliary subunits function in the assembly and membrane localization of the complex, and modulate calcium currents and channel activation/inactivation kinetics. The subunit encoded by this gene undergoes post-translational cleavage to yield the extracellular alpha2 peptide and a membrane-anchored delta polypeptide. This subunit is a receptor for the antiepileptic drug, gabapentin. Mutations in this gene are associated with early infantile epileptic encephalopathy. Single nucleotide polymorphisms in this gene are correlated with increased sensitivity to opioid drugs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.17).
BP6
Variant 3-50370310-C-T is Benign according to our data. Variant chr3-50370310-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 461305.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA2D2 | ENST00000424201.7 | c.2045+10G>A | intron_variant | Intron 23 of 37 | 1 | NM_006030.4 | ENSP00000390329.2 | |||
CACNA2D2 | ENST00000423994.6 | c.2066+10G>A | intron_variant | Intron 24 of 38 | 5 | ENSP00000407393.2 | ||||
CACNA2D2 | ENST00000266039.7 | c.2045+10G>A | intron_variant | Intron 23 of 37 | 1 | ENSP00000266039.3 | ||||
CACNA2D2 | ENST00000360963.7 | c.1838+10G>A | intron_variant | Intron 23 of 37 | 1 | ENSP00000354228.3 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151772Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
6
AN:
151772
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000461 AC: 9AN: 195324Hom.: 0 AF XY: 0.0000575 AC XY: 6AN XY: 104430
GnomAD3 exomes
AF:
AC:
9
AN:
195324
Hom.:
AF XY:
AC XY:
6
AN XY:
104430
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000449 AC: 64AN: 1423842Hom.: 1 Cov.: 31 AF XY: 0.0000454 AC XY: 32AN XY: 704730
GnomAD4 exome
AF:
AC:
64
AN:
1423842
Hom.:
Cov.:
31
AF XY:
AC XY:
32
AN XY:
704730
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151772Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74088
GnomAD4 genome
AF:
AC:
6
AN:
151772
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74088
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Early infantile epileptic encephalopathy with suppression bursts Benign:1
Jul 25, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at